Literature DB >> 2079078

Excessive urinary oxalate excretion after combined renal and hepatic transplantation for correction of hyperoxaluria type 1.

H Ruder1, G Otto, R B Schutgens, U Querfeld, R J Wanders, K H Herzog, P Wölfel, S Pomer, K Schärer, G A Rose.   

Abstract

A 4.5-year-old boy received a combined liver and kidney transplant for correction of hyperoxaluria type 1. Both organs were from the same donor and functioned primarily. Three months after transplantation, urine oxalate excretion reached a maximum of 10,500 mumol/24 h and remained above 2300 mumol/24 h for the next 2 months. Two months later, oxalate excretion decreased to about 565 mumol/24 h, indicating exhaustion of a large oxalate pool. Six months after transplantation plasma oxalate is near normal (4.9 mumol/l). With the exception of one episode of acute rejection of the renal transplant, both organs were tolerated well and continue to have a unimpaired function 9 months after transplantation. However, there is increased echogenity on renal ultrasound, indicating oxalate deposits in the grafted kidney. This case illustrates that successful combined transplantation of both liver and kidney can be performed in infants, resulting in cure of the metabolic defect. The prolonged or acute excretion of oxalate may lead to oxalate deposition in the grafted kidney without impaired graft function or early graft loss.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2079078     DOI: 10.1007/BF01959482

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  15 in total

1.  Long-term outcome of kidney transplantation in children with oxalosis.

Authors:  A Katz; Y Kim; J Scheinman; J S Najarian; S M Mauer
Journal:  Transplant Proc       Date:  1989-02       Impact factor: 1.066

Review 2.  Recent advances in the understanding, diagnosis and treatment of primary hyperoxaluria type 1.

Authors:  C J Danpure
Journal:  J Inherit Metab Dis       Date:  1989       Impact factor: 4.982

3.  Kidney transplantation in primary oxalosis: data from the EDTA Registry.

Authors:  M Broyer; F P Brunner; H Brynger; S R Dykes; J H Ehrich; W Fassbinder; W Geerlings; G Rizzoni; N H Selwood; G Tufveson
Journal:  Nephrol Dial Transplant       Date:  1990       Impact factor: 5.992

4.  Measurement of plasma oxalate in healthy subjects and in patients with chronic renal failure using immobilised oxalate oxidase.

Authors:  G P Kasidas; G A Rose
Journal:  Clin Chim Acta       Date:  1986-01-15       Impact factor: 3.786

5.  Human liver L-alanine-glyoxylate aminotransferase: characteristics and activity in controls and hyperoxaluria type I patients using a simple spectrophotometric method.

Authors:  R J Wanders; J Ruiter; C W van Roermund; R B Schutgens; R Ofman; S Jurriaans; J M Tager
Journal:  Clin Chim Acta       Date:  1990-08-15       Impact factor: 3.786

6.  [Type I oxalosis in childhood--studies within the scope of terminal renal failure in the child].

Authors:  M Frosch; E Kuwertz-Bröking; M Bulla; D B von Bassewitz; D B Leusmann
Journal:  Klin Wochenschr       Date:  1989-11-17

7.  Early liver transplantation for primary hyperoxaluria type 1 in an infant with chronic renal failure.

Authors:  G Schürmann; K Schärer; A M Wingen; G Otto; C Herfarth
Journal:  Nephrol Dial Transplant       Date:  1990       Impact factor: 5.992

8.  Primary hyperoxaluria (type I): attempted treatment by combined hepatic and renal transplantation.

Authors:  R W Watts; R Y Calne; R Williams; M A Mansell; N Veall; P Purkiss; K Rolles
Journal:  Q J Med       Date:  1985-10

Review 9.  Perspectives in the assessment and management of patients with primary hyperoxaluria type I.

Authors:  S H Morgan; R W Watts
Journal:  Adv Nephrol Necker Hosp       Date:  1989

10.  Peroxisomal alanine:glyoxylate aminotransferase deficiency in primary hyperoxaluria type I.

Authors:  C J Danpure; P R Jennings
Journal:  FEBS Lett       Date:  1986-05-26       Impact factor: 4.124

View more
  6 in total

Review 1.  Primary hyperoxalurias: diagnosis and treatment.

Authors:  Efrat Ben-Shalom; Yaacov Frishberg
Journal:  Pediatr Nephrol       Date:  2014-12-18       Impact factor: 3.714

2.  Sustained pyridoxine response in primary hyperoxaluria type 1 recipients of kidney alone transplant.

Authors:  E C Lorenz; J C Lieske; B M Seide; A M Meek; J B Olson; E J Bergstralh; D S Milliner
Journal:  Am J Transplant       Date:  2014-05-02       Impact factor: 8.086

3.  Transplantation outcomes in primary hyperoxaluria.

Authors:  E J Bergstralh; C G Monico; J C Lieske; R M Herges; C B Langman; B Hoppe; D S Milliner
Journal:  Am J Transplant       Date:  2010-09-17       Impact factor: 8.086

4.  Oxalate quantification in hemodialysate to assess dialysis adequacy for primary hyperoxaluria.

Authors:  Xiaojing Tang; Nikolay V Voskoboev; Stacie L Wannarka; Julie B Olson; Dawn S Milliner; John C Lieske
Journal:  Am J Nephrol       Date:  2014-04-26       Impact factor: 3.754

Review 5.  Should liver transplantation be performed before advanced renal insufficiency in primary hyperoxaluria type 1?

Authors:  P Cochat; K Schärer
Journal:  Pediatr Nephrol       Date:  1993-04       Impact factor: 3.714

Review 6.  Recurrence of crystalline nephropathy after kidney transplantation in APRT deficiency and primary hyperoxaluria.

Authors:  Guillaume Bollée; Pierre Cochat; Michel Daudon
Journal:  Can J Kidney Health Dis       Date:  2015-09-15
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.